title: Minimally invasive convection-enhanced delivery of biologics into dorsal root ganglia: validation in the pig model and prospective modeling in humans. Technical note.
abstract: Dorsal root ganglia (DRG) are critical anatomical structures involved in nociception. Intraganglionic (IG) drug delivery is therefore an important route of administration for novel analgesic therapies. Although IG injection in large animal models is highly desirable for preclinical biodistribution and toxicology studies of new drugs, no method to deliver pharmaceutical agents into the DRG has been reported in any large species. The present study describes a minimally invasive technique of IG agent delivery in domestic swine, one of the most common large animal models. The technique utilizes CT guidance for DRG targeting and a custom-made injection assembly for convection enhanced delivery (CED) of therapeutic agents directly into DRG parenchyma. The DRG were initially visualized by CT myelography to determine the optimal access route to the DRG. The subsequent IG injection consisted of 3 steps. First, a commercially available guide needle was advanced to a position dorsolateral to the DRG, and the dural root sleeve was punctured, leaving the guide needle contiguous with, but not penetrating, the DRG. Second, the custom-made stepped stylet was inserted through the guide needle into the DRG parenchyma. Third, the stepped stylet was replaced by the custom-made stepped needle, which was used for the IG CED. Initial dye injections performed in pig cadavers confirmed the accuracy of DRG targeting under CT guidance. Intraganglionic administration of adeno-associated virus in vivo resulted in a unilateral transduction of the injected DRG, with 33.5% DRG neurons transduced. Transgene expression was also found in the dorsal root entry zones at the corresponding spinal levels. The results thereby confirm the efficacy of CED by the stepped needle and a selectivity of DRG targeting. Imaging-based modeling of the procedure in humans suggests that IG CED may be translatable to the clinical setting.
authors.affiliation: Departments of Anesthesiology.
authors.forename: Josef
authors.initials: J
authors.lastname: Pleticha
authors.forename: Timothy P
authors.initials: TP
authors.lastname: Maus
authors.forename: Jodie A
authors.initials: JA
authors.lastname: Christner
authors.forename: Michael P
authors.initials: MP
authors.lastname: Marsh
authors.forename: Kendall H
authors.initials: KH
authors.lastname: Lee
authors.forename: W Michael
authors.initials: WM
authors.lastname: Hooten
authors.forename: Andreas S
authors.initials: AS
authors.lastname: Beutler
mesh_terms: D000818:Animals; D001688:Biological Products / Q000008:administration & dosage*; D018481:Convection; D005727:Ganglia, Spinal; D006801:Humans; D007267:Injections / Q000379:methods; D023421:Models, Animal; D034421:Sus scrofa; D014057:Tomography, X-Ray Computed
chemical_list: D001688:Biological Products
keywords: AAV = adeno-associated virus; AAV1 = AAV serotype 1; CED = convection-enhanced delivery; CTF = CT fluoroscopy; DRG = dorsal root ganglia; EGFP = enhanced green fluorescent protein; IG = intraganglionic; PBS = phosphate-buffered saline; computed tomography; convection-enhanced delivery; dorsal root ganglia; gene therapy; intraganglionic injection; pain; peripheral nerve